Journal Information
Most Often Read
2805
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic reviewA. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi
Pulmonol. 2021;27:52-66
2805
Open access
Open Article
1831
COVID-19 effects on tuberculosis care in Sierra LeoneD. Buonsenso, F. Iodice, J. Sorba Biala, D. Goletti
Pulmonol. 2021;27:67-9
1831
Open access
Open Article
1521
The role of non-invasive ventilation in weaning and decannulating critically ill patients with tracheostomy: A narrative review of the literatureMiguel Guia, Laura D Ciobanu, Jithin K Sreedharan, Mohamed E. Abdelrahim, Gil Gonçalves, Bruno Cabrita, Jaber S. Alqahtani, Jun Duan, Mohamad El-Khatib, Montserrat Diaz-Abad, Jakob Wittenstein, Habib M.R. Karim, Pradipta Bhakta, Paolo Ruggeri, Giancarlo Garuti, Karen E.A. Burns, Guy W. Soo Hoo, Raffaele Scala, Antonio Esquinas
Pulmonol. 2021;27:43-51
1521
Open access
1440
Translating Idiopathic pulmonary fibrosis guidelines into clinical practiceC. Robalo-Cordeiro, A. Morais
Pulmonol. 2021;27:7-13
1440
Open access
1312
Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency roomR. Singla, B. Raghu, A. Gupta, J.A. Caminero, P. Sethi, D. Tayal, A. Chakraborty, Y. Jain, G.B. Migliori
Pulmonol. 2021;27:35-42
1312
Open access
1255
The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancerA. Sakin, S. Sahin, M.M. atci, N. Yasar, C. Geredeli, F. Aksaray, S. Cihan
Pulmonol. 2021;27:26-34
1255
Open access
1226
The “Big Five” Lung Diseases in CoViD-19 Pandemic – a Google Trends analysisM.T. Barbosa, M. Morais-Almeida, C.S. Sousa, J. Bousquet
Pulmonol. 2021;27:71-2
1226
Open access
1183
Low dose computed tomography of the lung for detection and grading of interstitial lung disease: A systematic simulation studyS. Ley, L. Fidler, H. Schenk, M. Durand, T. Marras, N. Paul, S. Shapera, S. Mittoo
Pulmonol. 2021;27:14-25
1183
Open access
1158
Alpha-1-antitrypsin deficiency (AATD) and spontaneous pneumothorax: Guidelines do not recommend screening for AATD in patients with pneumothorax – What did we find in 10 years of clinical evidence?E. Dias, I. Farinha, F. Costa
Pulmonol. 2021;27:80-1
1158
Open access
1017
Tuberculosis — Reaping benefits from COVID-19 in PortugalB.L. Mateiro Gomes, I. Carvalho
Pulmonol. 2021;27:4-6
1017
Open access
Open Article
948
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the maskClaudia Crimi, Annalisa Carlucci
Pulmonol. 2021;27:1-3
948
Open access
Open Article
921
Rhodococcus equi infection as inaugural manifestation of idiopathic CD4+ lymphopenia: A rare entity and a therapeutic challengeA. Alves, E. Silva, T. Teixeira, C. Figueiredo, A. Lameirão, M. Vanzeller, C. Ribeiro
Pulmonol. 2021;27:75-7
921
Open access
899
Total volume/week of physical activity: an underused variable of physical activity in daily life in patients with copd and its association with exercise capacityLorena P. Schneider, Felipe V.C. Machado, Antenor Rodrigues, Raquel P. Hirata, Daniele C. Dala Pola, Mariana P. Bertoche, Letícia F. Belo, Ana Carolina dos Reis Andrello, Jéssica Fonseca, Leandro C. Mantoani, Karina C. Furlanetto, Fabio Pitta
Pulmonol. 2021;27:73-5
899
Open access
837
Extracorporeal membranous oxygenation for a severe case of vaping associated lung injuryM.R. Regmi, N. Tandan, P. Parajuli, R. Maini, O.E. Lara Garcia, P. Jagtap, A. Kulkarni
Pulmonol. 2021;27:69-70
837
Open access
822
Wearing masks and the fight against the novel coronavirus (COVID-19)Javad Alizargar
Pulmonol. 2021;27:89
822
Open access
791
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?C.S. Kow, S.S. Hasan
Pulmonol. 2021;27:86-7
791
Open access
Open Article
722
First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patientS. Pecho-Silva, A.C. Navarro-Solsol
Pulmonol. 2021;27:77-9
722
Open access
662
Secondary pulmonary alveolar proteinosis in a patient with systemic lupus erythematosusM. Yamasaki, K. Kawamoto, S. Nakano, M. Taniwaki, N. Matsumoto, N. Hattori
Pulmonol. 2021;27:81-3
662
Open access
553
Spontaneous pneumomediastinum: Beyond the risky divingJordi Juanola-Pla, Mireia Carmona-Tomàss, Sonia Casals-Vila
Pulmonol. 2021;27:88-9
553
Open access
Special content about COVID-19
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
